09/2009 - 09/2011: General doctor - Hanoi Medical University
09/2011 - 08/2014: Radiology resident doctor - Hanoi Medical University
09/2017 - 09/2019: Radiology specialist doctor II - Hanoi Medical University
Specialist doctor II Le Thi My has 10 year experiences in the field of Diagnostic Imaging.
Dr. My is the doctor in developing technology for thyroid radiofrequency ablation (thyroid tumor, metastatic lymph node after thyroid cancer surgery, parathyroid tumor) in the North of Vietnam. Destruction in the pot of liver tumors by methods of radiofrequency ablation, microwave ablation.
09/2009 - 09/2011: General doctor - Hanoi Medical University
09/2011 - 08/2014: Radiology resident doctor - Hanoi Medical University
09/2017 - 09/2019: Radiology specialist doctor II - Hanoi Medical University
9/2011 - 10/2014: Bác sĩ nội trú - Khoa chẩn đoán hình ảnh - Bệnh viện Bạch Mai
11/2014 - 8/2020: Bác sĩ chẩn đoán và chẩn đoán can thiệp - Trung tâm Điện Quang - Bệnh viện Bạch Mai
9/2020 - đến nay: Giám đốc Trung tâm bệnh lý tuyến giáp - Trung tâm bệnh lý tuyến giáp - Khoa Chẩn đoán hình ảnh & Y học hạt nhân - Bệnh viện Đa khoa Quốc tế Vinmec Times City
Hội Điện quang và Y học hạt nhân Việt Nam
2015: “Initial effectiveness of application radiofrequency ablation in liver cancer”, which is public on Dien Quang Journal No.18, Bach Mai Hospital.
2013 - 2015: Completed basic project “Initial effectiveness of HCC treatment by chemical embolization combined with radiofrequency ablation".
04/2014: Report at Dien Quang Conference "Evaluating the effectiveness of radiofrequency ablation with artificial pleural effusion and artificial peritoneal effusion in the treatment of hepatocellular carcinoma" at Bach Mai Hospital
2017 - 2018: Completed basic project "The value of transverse tissue elastography in diagnosing the degree of liver fibrosis".
2017 - present: Clinical trial study with the role of Sub - investigator "Phase III, randomized, double-blind, double-simulated, placebo-controlled study of ThermoDox® (Lyso-Thermosensitive Liposomal Doxorubicin- LTLD) in patients with hepatocellular carcinoma (HCC), using radiofrequency ablation (RFA), standardized with treatment duration 45 min for solitary lesions 3 cm to 7 cm
08/2018: Report of Interventional Radiology Conference about "Initial effectiveness of radiofrequency ablation in the treatment of hot nodules of the thyroid gland" in Bach Mai Hospital.
12/2019: "Initial effectiveness of treating thyroid nodules by high-frequency ablation, which is public in Dien Quang Journal No. 36.
2019: Invited Speaker at 6th, Asian Conference on Tumor Ablation (Taiwan) "Initial Effectiveness of Radiofrequency Ablation of the Autonomously Functioning Thyroid Nodules"
08/09/2020: (International paper, co-authored) Radiofrequency ablation of benign thyroid nodules: Recommendations from the Asian Conference on Tumor Ablation Task Force - Ultrasonography - Published online
06/01/2022: “Efficacy and safety of radiofequency ablation for the treatment of autonomously functioning thyroid nodules: A Long – Term prospective study” – Therapeutics and clinical risk management 2022:18 11-19.
19/10/2020: (International article, Co-authored) A case report of Mikulicz's disease - The Pan African Medical Journal - Volume 37, Article 252
Participating in writing books for specialized imaging: Interventional radiology in tumors, Computerized tomography techniques, Diagnostic Magnetic Resonance Imaging (MRI)
Participating in writing books for Endocrinology: "Diagnosing and treating thyroid nodules".